Rare diseases
Investigational molecules
Locations
Back to Estonia148 clinical trials in Tallin, Estonia across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in EstoniaKliinilisedUuringud.ee(opens in a new tab)Study on the Effectiveness and Safety of ESK-001 and Apremilast for Patients with Moderate to Severe Plaque Psoriasis
EstoniaStudy on the Effects of LNA043 for Patients with Knee Osteoarthritis
EstoniaStudy on the Effects of AGA2118 for Postmenopausal Women with Osteoporosis
EstoniaStudy of sonelokimab injection in adults with active psoriatic arthritis who have not received biological DMARDs treatment before
EstoniaStudy on the Effects and Safety of Guselkumab for Patients with Active Psoriatic Arthritis
EstoniaStudy on the Effectiveness and Safety of CHF6001 DPI with Roflumilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis
EstoniaStudy on the Long-Term Safety and Efficacy of Nemolizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis
EstoniaStudy on the Effectiveness and Safety of Vibozilimod for Adults with Moderate to Severe Plaque Psoriasis
EstoniaStudy of Risankizumab vs. Placebo for Patients with Active Psoriatic Arthritis and Inadequate Response to DMARD Therapy
EstoniaStudy of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke
EstoniaStudy on the Effectiveness and Safety of Abatacept Biosimilar (DRL_AB) and Methotrexate for Patients with Moderate to Severe Rheumatoid Arthritis
EstoniaStudy on the Effectiveness and Safety of AVP-786 (Quinidine Sulfate and Deudextromethorphan Hydrobromide) for Treating Agitation in Alzheimer's Dementia Patients
EstoniaThe busiest research cities in the country
What the registry says about research in the country
Clinical investigations focusing on innovative treatments for ulcerative colitis, specifically targeting patients with mild to moderate left-sided manifestations of the condition. The research explores new therapeutic approaches using targeted delivery methods.
These trials aim to evaluate the effectiveness of a new localized treatment approach compared to placebo, potentially offering improved options for patients with inflammatory bowel conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
